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Abstract
Itch is a commonly experienced symptom of acute and chronic dermatological and systemic conditions. Placebo and nocebo
effects, positive and negative effects experienced after both real and sham interventions, putatively due to positive or negative
outcome expectancies, can have a significant impact on the experience of itch and its treatment. Experimental methods to induce
and study placebo and nocebo effects on itch have been developed, utilizing various combinations of expectancy-induction
methods (eg, conditioning, verbal suggestions) and short-acting itch-evoking stimuli (eg, histamine, electrical, or mechanical
stimulation). The aim of this review is to describe the current research methods used to induce placebo and nocebo effects on itch,
and the results of these studies. The benefits and drawbacks of different expectancy-induction methods and itch-evoking stimuli are
described, and future directions for research and clinical application are discussed.
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Itch is a commonly experienced and unpleasant bodily sensation
that motivates scratching behavior. Pruritic sensations can occur
as symptoms in acute and chronic dermatological conditions[1,2],
in systemic diseases such as renal failure[3], and in response to
cues in the environment[4]. There is evidence that expectancies,
beliefs influenced by observation, contextual factors, and prior
events, contribute to the experience of itch[5]. Expectancies are
the putative core mechanism underlying placebo and nocebo
effects. These effects describe the positive (placebo) or negative
(nocebo) response to active and inert interventions, for example
placebo or sham medication[6]. Understanding how expectancies
affect outcomes for pruritus can improve its clinical treatment
and expand our fundamental understanding of the factors which
affect physical sensations such as itch.
Experimental studies of placebo and nocebo effects on itch
typically combine expectancy-induction methods (eg, verbal
suggestion) with the administration of a pruritic stimulus to
induce a placebo or nocebo effect on the participants’ experience
of itch. The most frequently studied expectancy-induction
methods used in placebo and nocebo studies can be generally
grouped into 2 categories, verbal suggestions and conditioning.
Verbal suggestions induce outcome expectancies through explicit
instruction or suggestion (eg, instructions by the researcher or
health care professional). Classical conditioning is a type of
learning that forms and strengthens associations between stimuli
and outcomes through repeated pairings of their presentation[7].
The most well-known example of this process comes from
Pavlov’s[8] observations on the salivary reflex of dogs. Giving a
dog food naturally evokes a salivary response in anticipation of
the meal. Pavlov observed that other stimuli repeatedly presented
before the meal, such as the dog’s food bowl, the approaching
footsteps of the human bearing the food, or the sound of a bell,
could evoke a similar salivary reflex as the meal itself. Associative
learning through classical conditioning can occur both explicitly
(with conscious awareness of the learner) and implicitly (without
conscious awareness)[9]. The itch-evoking stimuli used so far in
research on placebo and nocebo effects, which include histamine,
electrical stimulation, mechanical stimulation, allergens, and
audiovisual stimuli, are all typically capable of inducing acute,
mild to moderate itch on a localized part of the body[10]. These
stimuli may vary across other attributes, such as administration
method, average duration of the itch response, or the resemblance
of the model with underlying mechanisms of various clinical
conditions. Consideration must be given to the attributes of the
expectancy-induction method and accompanying pruritic sti-
mulus when selecting the most suitable methods to address a
given research question.
Previous reviews of placebo and nocebo effects on itch have
addressed the mechanisms, predictors, and clinical relevance of
these effects[11–13]. The current review aims to build on this work
and fill a gap in the literature by providing an overview of the
methods used to induce placebo and nocebo effects on itch.
Common benefits and drawbacks of these methods will be
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described, and potential advances through future research in
placebo-induction and nocebo-induction methods for itch will be
discussed. First, we describe the expectancy-induction methods
used to study placebo and nocebo effects, and the results of stu-
dies in this field. This is followed by an overview of the itch-
evoking stimuli most frequently used in placebo and nocebo
studies. Finally, we discuss the current literature and provide
suggestions for future research.
Expectancy-induction methods
Studies of placebo and nocebo effects on itch typically pair an
expectancy-induction method (ie, verbal suggestions, condition-
ing)with one ormore itch-evoking stimuli (summarized inTable 1)
to induce a placebo or nocebo effect on itch. In this section we
review the findings of experiments that employed verbal sugges-
tions, conditioning, and their combination, to study placebo and
nocebo effects on itch.
Verbal suggestions
Verbal suggestions provide participants with information that
can induce and modify their expectancies for future outcomes[34].
Studies of placebo and nocebo effects on itch, like those on
pain[35], most frequently make use of verbal suggestion, as this
method has proven effective at inducing expectancies and can be
relatively easily incorporated into instructions given to partici-
pants in an experiment, or to patients in clinical practice.
Placebo effects
Research on the efficacy of verbal suggestions for inducing placebo
effects on itch has yielded mixed results. Verbal suggestions for
placebo effects on itch have been made for numerous placebo
interventions. These include: a suggestion of the positive, itch-
relieving effects of placebo lotions[36,37], a suggestion of the itch-
relieving andpain-relieving effects of a nasal spray[38], a suggestion of
the high likelihood of an effect of reduced physical sensitivity caused
by a placebo pill[39], a suggestion of the reduction of itch caused by
an electrode[19], and a suggestion of the effect of a (nonexistent)
itch-reducing agent added to a histamine iontophoresis
procedure[40]. These positive verbal suggestions were compared
with conditions which received no verbal suggestion[19,36–38], a
control verbal suggestion of a low likelihood of an effect of reduced
physical sensitivity caused by a pill[39], or a control verbal sugges-
tion of a high likelihood that participantswill experience itch during
a histamine iontophoresis procedure[40]. Following the verbal sug-
gestion or control treatment in each experiment, itch of a similar
intensity in both suggestion groups was then evoked with histamine
skin prick[36,37], histamine iontophoresis[38–40], or electrical
stimulation[19]. These studies compared participants’ perceived itch
intensity between the different verbal suggestion conditions during
the itch-evoking procedure, providing a measure of the placebo
effect. Only Darragh et al[37] were successful in reducing reported
itch sensations during the subsequent histamine skin prick proce-
dure. In this study, an extensive and detailed verbal suggestion
regarding the effects of an inert placebo lotion was used. Other
studies used verbal suggestions that were relatively short or broad
(not specific to itch) and did not find a significant placebo effect on
itch[19,36,39,40]. The mixed results of these experiments indicate that
further study of factors like the length, specificity, and content of a
suggestion is needed to understand the circumstances under which
verbal suggestions alone can induce placebo effects on itch.
Nocebo effects
Several experiments have tested the efficacy of verbal suggestions to
induce nocebo effects on itch[19,40–43]. The verbal suggestions used
in these studies include a suggestion of a high likelihood that par-
ticipants would experience itch during subsequent procedures[40], a
suggestion of the itch-evoking effect ofwatching a video of someone
scratching themselves[43], a suggestion of increased itch due to the
activation of an electrode[19], or a suggestion that gave an exag-
gerated description of the itch participants were likely to
experience[41,42]. The control treatments these verbal suggestion
groups were compared with include no verbal suggestion[19], a
verbal suggestion of a low chance of experiencing itch during sub-
sequent procedures[40], or a verbal suggestion that forthcoming
procedures would likely induce only a mild itch sensation[41–43].
Following the verbal suggestion or control treatment in each
Table 1
Attributes of the itch-evoking stimuli used in placebo and nocebo studies to date.











Rubbing with wool fibers[22], von Frey
monofilaments[23], vibration[24]
Skin prick[25] Presenting itch-evoking images[5,26],
videos[27–29], sounds of skin
scratching[30]
Duration 1–4 min following termination
of iontophoresis[15], other
methods 5–15 min[14,22]
Dependent on length of
stimulus
Mild itch for up to 2 min
past end of stimulus[18]
Dependent on length
of stimulus
Itch is typically felt for 1–2 s after
von Frey stimulus[23]
5–15 min[25] Variable, may depend on
stimulus material
Stability Stable response over repeated
administration[31]
Initially stable response[32],









Intensity is dose dependent at
certain concentrations[22]
Intensity responds to thermal
modulation[33]
Intensity can be modulated
by varying the strength of the
electric stimulus[18]







Intensity from auditory scratching
stimuli may be modulated by
increasing high frequency noise[30]
This table briefly summarizes the attributes of the itch-evoking stimuli which have been used in currently published placebo and nocebo effect studies.
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experiment, itch of similar intensity in both groupswas then evoked
with histamine skin prick[41,42], electrically evoked itch[19], and
histamine iontophoresis, mechanical stimulation, and electrical sti-
mulation in one study[40]. These studies measured the difference in
participants’ perceived itch intensity during the itch-evoking pro-
cedure after the different verbal suggestions, providing ameasure of
the nocebo effect. In each of these studies, participants receiving the
increased itch verbal suggestions experienced a significantly higher
itch intensity than the control participants who underwent the same
itch-evoking procedures[19,40–43]. Aside from Bartels et al[19], the
effects measured in these studies can be best described as nocebo-
like effects rather than nocebo effects, as the verbal suggestions did
not ascribe the increase in itch to an inert (nocebo) stimulus (eg, an
electrode or a pill). These studies demonstrate that the experience of
itch sensations can be influenced by verbal suggestions.
Conditioning and verbal suggestions
Placebo and nocebo effects can also be induced with conditioning,
particularly in combinationwith verbal suggestions. Animalmodels
of conditioning have demonstrated its ability to shape behavioral
responses to pain[44], and human models of placebo and nocebo
effects on pain have also been developed to investigate how these
effects are learned through conditioning[45–49]. In studies of placebo
and nocebo effects on itch, an association between an inert (placebo
or nocebo) stimulus (conditioned stimulus, CS) and a stimulus that
signals the evocation of itch (unconditioned stimulus, US, evoking
an unconditioned response, UCR) is formed by repeatedly pairing
the 2 stimuli during a training period (Fig. 1). After repeated trials,
the placebo or nocebo stimulus (CS) is intended to induce changes in
perceived itch intensity (conditioned response, CR) similar to the
intensity of itch previously evoked by theUS. This effect ismeasured
during a test phase where the CS is presented with an itch stimulus
of medium intensity, after having been associated with itch stimuli
of lesser (placebo) or greater (nocebo) intensity. Some studies on itch
have used only conditioning to induce placebo or nocebo effects,
but most have combined verbal suggestions with conditioning.
Combining verbal suggestions with conditioning provides the
means to target both explicit and implicit learning processes,
enhance the believability of a verbal suggestion, and the effective-
ness of conditioning for inducing expectancies.
Placebo effects
Only few studies have induced placebo effects on itch using con-
ditioning with verbal suggestions[19,20], as well as conditioning
Figure 1. A typical conditioning experiment for placebo and nocebo effects on itch. Different inert stimuli (the differently colored lotion tubes) are repeatedly paired
with itch stimuli of different intensities (the differently sized lightning bolts indicating different intensities of electrically evoked itch). During training, the associations
between a neutral stimulus and medium intensity itch, and between a reinforced stimulus and decreased (placebo) or increased (nocebo) itch responses is
conditioned through repeated exposure to the paired stimuli and itch responses. Verbal suggestions may also be used to strengthen the conditioned expectancies
regarding the effects of the inert placebo or nocebo stimulus. The effect of conditioning is then measured during a test phase, when the reinforced stimulus is
presented with medium intensity itch, and will be perceived as having lesser (placebo effect) or greater (nocebo effect) intensity.
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without verbal suggestions[19]. In these experiments, participants in
the verbal suggestion and conditioning group first received a verbal
suggestion describing the associations between 3 differently colored
stimuli which signaled the activation of a (sham) electrode, and
changes in itch stimulus intensity. Itch was evoked with electrical
stimulation (US), and one of the colored stimuli was paired with
low-intensity itch to serve as the CS. This pairing was repeatedly
presented to forman association between the colored stimulus and a
low level of itch (UCR), and through verbal suggestion participants
were led to believe that the reduction in itch was caused by the
activation of an additional electrode[19,20]. Conditioning alone did
not produce a significant placebo effect on perceived itch intensity,
whereas combining conditioning with a verbal suggestion did
produce a placebo effect, demonstrated by participants experien-
cing less itch (CR) during trials when the colored stimulus pre-
viously associated with a low level of itch was presented, relative to
trials containing the neutral colored stimulus, during a test phase
where the electrical stimulus intensity was identical for both trial
types. Bartels et al[20] also used the combination of verbal suggestion
and conditioning to counter-condition a previously induced nocebo
effect on itch (forming a new association between decreased itch
intensity and a colored stimulus previously associated with
increased itch) and thereby turned the nocebo effect into a placebo
effect. On the basis of these results, one can conclude that the
combination of verbal suggestion with conditioning is more effec-
tive than conditioning alone for inducing a placebo effect on itch.
Nocebo effects
Three studies so far have used conditioning methods with verbal
suggestions to induce nocebo effects on itch[19,25,33], one of which
also tested conditioning without verbal suggestions[19]. Participants
were conditioned to associate previously neutral stimuli such as a
skin prick procedure[25], activation of a sham transcutaneous elec-
trical nerve stimulation (TENS) device[33], or colored stimuli indi-
cating the activation of a sham electrode[19], with the US of
increased itch intensity. In these experiments, itch was evoked with
an allergen skin prick[25], histamine[33], or electrical stimulation[19].
In Napadow et al[25], a single administration of allergen skin prick
(US) to evoke itch (UCR) followed by thermalmodulationwas used
to condition an association between thermal modulation after a
skin prick procedure (CS) and the itch evoked by the allergen skin
prick in patients with atopic dermatitis. When the skin prick was
later performed with saline, a verbal suggestion telling the partici-
pants that the saline skin prick actually contained histamine was
given. As a result, these participants experienced more itch (CR)
compared with participants who were told that the second skin
prick contained only saline. Van de Sand et al[33] conditioned a
nocebo effect using thermal modulation of histamine-evoked itch
(US) to repeatedly modulate itch intensity between a baseline tem-
perature (low itch) and cool temperature (high itch, UCR).
Participantswere told that a TENS device (CS)was activated during
the cooling phases of thermal modulation to form an association
between activation of the TENS device and increased itch during
cooling. A verbal suggestion explaining the role of the TENS device
and its effects on itch was made to the participants prior to con-
ditioning. During a subsequent test, the participants experienced
increased itch on cooling trialswhen theywere told theTENSdevice
was active (CR), as compared with cooling trials when the partici-
pantswere told the TENSdevicewas not active. Bartels et al[19] used
repeated trials of electrical stimulation (US) paired with 3 different
colored light stimuli to form an association between one of the
colored stimuli (CS) and the electrical stimulation, which was sur-
reptitiously increased to evoke a high level of itch (UCR)[19]. In one
condition, participants were additionally given a verbal suggestion
that explained which colored stimulus signaled high and low levels
of itch caused by activation or deactivation of a (sham) electrode.
While conditioning without verbal suggestion did not induce a
significant nocebo effect on itch, the combination of conditioning
with verbal suggestion did induce a nocebo effect, demonstrated by
participants experiencing increased itch during trials when the
colored stimulus previously paired with the high level of itch was
presented (CR), relative to trials in which the other colored stimuli
were presented. This finding from Bartels et al[19] is in line with
the other studies described in this section which induced nocebo
effects on itch with a combination of verbal suggestion and
conditioning[19,25,33]. Although it may be possible to induce nocebo
effects with conditioning alone, the evidence so far suggests that
nocebo effects on itch are most effectively induced with a combi-
nation of verbal suggestion and conditioning methods.
Itch-evoking methods
Several different substances have been used as pruritic stimuli in
placebo and nocebo studies so far, and an overview of the most
frequently used stimuli is provided inTable 1. Histamine is themost
commonly administered itch-evoking stimulus in these studies,
followed by electrical stimulation, mechanical stimulation, aller-
gens, and audiovisual stimuli. Previous reviews offer an extensive
description of a wide range of pruritogens[10,50]. Here we will focus
specifically on the pruritic stimuli which have been used in placebo
and nocebo studies, with special attention paid to the attributes of a
pruritic stimulus most relevant to their utility in the context of a
typical placebo or nocebo experiment. We consider 5 attributes. (1)
The method of administration, as effective placebos and nocebos
should have a plausible interaction with the method of evoking itch
so that an individual can readily form an expectation regarding the
effect of the placebo or nocebo on the experience of itch. (2) The
typical duration of itch evoked by the pruritic stimulus, as this
attribute affects how many times a pruritic stimulus can feasibly be
administered in a given experiment. In general, a greater number of
administrations is desirable when using conditioning methods. (3)
The stability of the itch response over repeated administrations. A
stable itch response to a pruritic stimulus across repeated adminis-
trations is beneficial to placebo and nocebo studies, where within-
subject variability in the itch response creates noise in the data. (4)
Whether multiple, distinct itch intensities can be evoked. To con-
dition placebo and nocebo effects, evoking itch at 2 ormore distinct
intensities is necessary so that individuals associate the placebo-
reinforced or nocebo-reinforced trials with experiencing lesser or
greater itch, respectively. (5) Whether the model resembles the
underlying mechanisms of a clinical condition. The clinical trans-
ferability of a pruritic stimulus to a given condition (eg, urticaria) is
an important attribute to be considered when seeking to make
comparisons from laboratory research to clinical practice.
Histamine
Histamine evokes a localized sensation of mild to moderate itch,
along with a wheal (local edema) and axon reflex flare response
(neurogenic inflammation) when administered to the epidermis[51].
Methods for efficient administration of histamine dihydrochloride or
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diphosphate solutions into the epidermis include skin prick, ionto-
phoresis, administration via inert cowhage spicules, and by scratch-
ing or scrubbing the skin. Histamine skin prick creates access to the
epidermis by piercing the skinwith a lancetwhere histamine has been
administered[14]. Histamine iontophoresis utilizes a mild electric
current to pass histamine through the dermis when histamine is
applied onto the skin[15]. Cowhage spicules made inert through
autoclaving and soaked in histamine can be administered by rubbing
the spicules into the skin[52]. Scratching and scrubbing away the
outermost layers of the dermis can be used to evoke itch with topical
administration of histamine to the treated area[16,17]. In general,
histamine-evoked itch lasts for ~5–15 minutes regardless of the
administration method[31,33,53]. Repeated application of histamine is
not known to cause habituation or reduced itch, and one studywhich
reported on the test-retest reliability showed a strong positive corre-
lation for the amount of itch evoked by 2 histamine administrations
occurring a week apart[31]. Studies which investigated the effect of
administering histamine in different concentrations have found that
the amount of itch evoked by histamine is dose-dependent, with a
higher concentration of histamine corresponding to increased itch[22],
although there appears to be a ceiling effect for concentrations
stronger than 1% histamine dihydrochloride[52,54]. One study
demonstrated that an increased iontophoretic current was associated
with an increase in itch[55]. Histamine-evoked itch intensity can also
be manipulated with thermal modulation, in which cooling the skin
at the site of histamine administration produces a brief, reversible
increase in itch intensity[56–58]. Experimentally evoked histaminergic
itch can be used as a model for urticaria.
Electrical stimulation
Administering amild electric current through electrodes attached to
the body (typically on the volar forearm) evokes itch in most
participants[19,59,60]. Unlike histamine, electrical stimulation does
not produce a visible wheal and flare reaction on the skin[18].
Several types of electrodes have been used in studies of electrically
evoked itch, including wire electrodes[18] and various reusable and
disposable surface electrodes[19–21]. Surface electrodes have been
usedmore commonly thanwire electrodes to evoke itch; however, a
comparison of the itch evoked by different types of electrodes is
required to conclude whether one is more effective for evoking itch.
After receiving an electrical stimulus, a participant will typically
experience mild to moderate itch sensations. The duration of the
itch response is dependent upon the duration of the electrical sti-
mulus, and itch typically dissipates within one to twominutes of the
end of the stimulus. The stability of electrically evoked itch
responses may depend on the number of stimuli used. Although
nearly all participants initially experience itch in response to elec-
trical stimulation[32], the evidence so far suggests that as many as
20% of participants may become desensitized to electrically evoked
itch overmany trials, aswas the case in a study that administered 33
electrical stimuli[20]. The intensity of electrically evoked itch can be
manipulated by varying the strength of the electric current used to
evoke itch[18]. On the basis of our current knowledge of electrically
evoked itch and clinical pruritic conditions, this method of itch-
induction does not appear to resemble the underlying mechanisms
of a clinical condition.
Mechanical stimulation
Low levels of itch can be evoked with mechanical stimulation of a
participant’s skin[23]. Methods of administering mechanically
evoked itch include rubbing wool fibers on the skin[22], pressure
from von Frey monofilaments[23], and applying vibration pro-
duced by a tuning fork[24]. Only mechanical stimulation by von
Frey monofilaments have been used in placebo and nocebo stu-
dies. The duration of itching sensations evoked by mechanical
stimulation is short, and abates within seconds of the stimulation.
The stability of mechanically evoked itch is relatively poor. One
study reported that across participants, ~40% of trials with von
Frey monofilaments evoked no itch, indicating that there is a high
degree of intravariability in participants’ responses to mechanical
stimulation[22]. Methods to modulate the intensity of mechani-
cally evoked itch have not been reported to our knowledge, and
such methods would likely be challenged by the low degree of
stability in responses to mechanical-itch stimuli, and the low
ceiling of itch intensity. The resemblance of mechanically evoked
itch to the underlying mechanisms of clinical pruritic conditions
requires further study.
Allergens
Allergens such as grass pollens and dust mites can be applied as
itch-evoking stimuli to participants who are allergic to at least one
of these compounds[61]. When administered via skin prick, such
as in allergy testing, these compounds evoke an allergic itch
response[62]. Allergic hypersensitivity to at least one allergen is
believed to be prevalent in ~25% of the population in indus-
trialized nations[63], and the use of allergens as a pruritic stimulus
is limited to populations that test positive for an allergic response
to a given allergen. In this subset of the population, allergens can
evoke itch of a similar duration and intensity to that of histamine
(ie, mild to moderate itch for 5–15min)[25]. The stability of the
itch response to allergens over repeated administrations has not
been reported on to our knowledge. One study has shown that the
intensity of allergen-evoked itch can bemanipulated with thermal
modulation, similar to histamine-evoked itch[25]. Allergens pro-
vide a clinical model of itch that may be used when researchers
wish to study placebo and nocebo effects in allergic reactions.
Audiovisual stimuli
Contagious itch, the pruritic effect of viewing itch related stimuli such
as videos of people scratching themselves, offers a purely psycholo-
gical method of evoking itch. Researchers have demonstrated the
pruritic effect of audiovisual stimuli with methods including images
depicting scratching and skin conditions[5,26], videos of people
scratching themselves[27–29], and auditory stimuli depicting the
sounds of scratching skin[30]. Such audiovisual stimuli appear to
evokemild to moderate itch; however, a systematic comparison with
a physiological itch-evoking stimulus (eg, histamine) has not been
reported, which would help determine how much itch audiovisual
stimuli evoke relative to other itch-evoking stimuli. The duration of
itch evoked with audiovisual stimuli may vary with the length of the
stimulus, and can persist after the stimulus has ended. The stability of
the itch response to audiovisual stimuli has not been studied yet. The
subjective intensity of audiovisual itch has been successfully modu-
lated by manipulating the high frequency volume of scratching
sounds, with increased high frequency volume contributing to
increased itch intensity[30]. Itch evoked with audiovisual stimuli does
not resemble a clinical model of itch; however, patients with atopic
dermatitus (AD) are more sensitive to audiovisual itch stimuli than
healthy controls[29]. For a thorough review of the research on con-
tagious itch, see Schut et al[4].
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Discussion
In this review, we have described the most commonly used
methods of inducing expectancies and evoking itch to study
placebo and nocebo effects. Several methods of evoking itch
(Table 1) have been combined with expectancy-induction meth-
ods (Fig. 1) to induce placebo and nocebo effects on itch in both
healthy and clinical samples. Here we discuss the most important
conclusions, future research directions, and clinical implications
for studies of placebo and nocebo effects on itch.
Expectancy-induction methods
Regarding expectancy-induction methods, it can be concluded that
verbal suggestions are a simple and effective method of inducing
nocebo effects on itch, whereas the findings for inducing placebo
effects are mixed. However, both placebo and nocebo effects on itch
appear to be weaker when induced with verbal suggestions alone
compared to verbal suggestions with conditioning[19], a finding that
also holds true for pain[47]. In the larger literature on placebo and
nocebo effects on pain, verbal suggestions have been found to be an
effective means of inducing placebo and nocebo effects (for review,
see Koban et al)[35], whereas for itch verbal suggestions appear more
effective for inducing nocebo effects than placebo effects. To use
verbal suggestions most effectively, the content of the verbal sug-
gestion should be believable, and contextual factors such as the
laboratory environment and professional demeanor of the experi-
menter likely contribute to the effect[64]. A possible future direction
for research with verbal suggestions is the investigation of open-label
verbal suggestion. One recent study[65] employed an open-label ver-
bal suggestion, wherein participants were explicitly told that the
purpose of verbal suggestions was to induce expectations regarding
itch intensity, and that verbal suggestions are effective even when
participants are informed of this purpose. The open-label suggestion
produced an effect on participant’s expected itch intensity, but did
not affect experienced itch during a histamine iontophoresis proce-
dure. Future research on open-label suggestions could investigate
how their effects on expectancies and perceived itch may differ from
closed label suggestions, as this difference is not yet understood and
may help to explain the factorswhich determine the efficacy of verbal
suggestions. Whether the effects of open-label verbal suggestions can
be reinforced with open-label conditioning also remains to be stu-
died.Given the limited results for inducing placebo effectswith verbal
suggestion alone, more research is needed to understand the factors
which make verbal suggestions effective, and why it may be more
effective for inducing nocebo effects than placebo effects. However,
the finding that learning for negative stimuli occursmore readily than
for positive stimuli has been demonstrated across many domains of
psychology and may be attributed to an evolutionary bias toward
attending to negative, potentially threatening stimuli over positive,
nonthreatening stimuli[66].
Conditioning, when combined with verbal suggestion, is an
effective method for inducing placebo and nocebo effects on
itch[19,20,25,33]. Many studies of placebo and nocebo effects on
pain further support the efficacy of conditioning in placebo and
nocebo inductions (for review, see Bräscher et al)[67]. However,
given the small number of studies investigating placebo and
nocebo effects on itch which used verbal suggestion with con-
ditioning, many lines of research have yet to be explored. While
Bartels et al[20] examined the unique and combined contributions
of verbal suggestion and conditioning to placebo and nocebo
effects on itch, it would be relevant to replicate these findings and
to conduct a similar experiment using neuroimaging methods
such as functional magnetic resonance imaging (fMRI) to com-
pare the neural effects of verbal suggestion and conditioning. A
detailed understanding of the interaction of verbal suggestion and
conditioning on placebo and nocebo effects will be important for
advancing effective treatments for itch in dermatological and
systemic disorders. For example, a recent study[20] showed that
counterconditioningmay prove to be effective for treating nocebo
effects on itch, and with further study we can understand its
treatment potential and mechanisms of action.
Itch-evoking methods
Histamine application is a highly effective method of evoking itch
and is the most frequently used itch-evoking stimulus in placebo
and nocebo effect studies. Histamine may evoke a more stable
itch response over repeated applications than the other itch-
evoking methods commonly used in placebo and nocebo studies.
However, disadvantages such as the duration of histamine-
evoked itch, and the challenges of reliably modulating the
intensity of histaminergic itch remain. The visible wheal and flare
response associated with histaminergic itch may also act as a
confounder to expectancy conditioning (eg, the severity of the
skin response may confound expectancies for less intense itch).
Methods to modulate histaminergic itch intensity, such as
applying different concentrations of histamine, modulating the
electric current of iontophoresis, and thermal modulation of
histaminergic itch show some promise, although these methods
are not without limitations. For example, different concentra-
tions of histamine can induce different itch intensities in a dose-
dependent relationship in concentrations ranging from 0%–1%
histamine dihydrochloride[52], but the number of potential
administrations is still limited by the time it takes for the previous
histamine administration to wear off. Histamine is a useful model
of pruritic symptoms in histaminergic itch conditions, such as
urticaria. To further advance the practicality of studying placebo
and nocebo effects with histamine-evoked itch, systematic ana-
lysis of the interaction between factors such as histamine con-
centration and administration method would be a useful line of
future research.
Electrically and mechanically evoked itch have been used less
frequently than histamine in placebo and nocebo research, and both
warrant further investigation. Electrically evoked itch, although
limited by a proportion of participants who may stop experiencing
itch following repeated stimulation, is so far the most effective
method of evoking multiple distinct levels of itch intensity repeat-
edly. The time needed for itch to dissipate between stimuli is also
considerably shorter than that of histamine-evoked itch. These traits
make it a potentially useful method for placebo or nocebo con-
ditioning studies, though the risk of participants not experiencing
itch from the electrical stimuli after repeated administrations must
be considered. As for mechanically evoked itch, only von Frey
monofilaments have been used in a single study of nocebo effects on
itch[40]. Othermeans ofmechanical stimulation, such as rubbing the
skin with wool fibers[22] or applying vibration[24] have also been
shown to evoke mild itch (although only on the chin in the case of
vibration). These methods could be further explored in placebo and
nocebo research as possible means of studying these effects with less
burden placed on the participants. However, this method is not
ideal for placebo effect studies because the low intensity of
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mechanically evoked itch leaves little room for a placebo-induced
reduction of itch.Mechanical stimulationmay also be an interesting
vehicle to study the generalization of placebo and nocebo effects
from other, more intense itch-evoking stimuli, for example to
investigate whether alloknesis and hyperknesis can be induced via
nocebo inductions. While electrically and mechanically evoked itch
possess useful attributes for laboratory research such as their rela-
tively short duration, their potential resemblance to themechanisms
of clinical pruritic conditions requires further study. Neither hista-
mine, nor electrical or mechanical stimulation are thought to evoke
itch by acting on the class of peripheral C fibers affected in most
chronic dermatological conditions like AD, thus limiting their use
when making comparisons to such chronic pruritic conditions.
Cowhage spicules (Mucuna pruriens) which evoke itch when
rubbed or pricked into the skin, may act via proteinase-activated
receptor (PAR) 2 and 4, orMas-relatedGprotein-coupled receptors
(MRGPRs)[68,69]. PAR receptors are believed to mediate itching
sensations in AD given the increased levels of endogenous PAR2
agonist tryptase observed in AD patients[70], and MRGPRs have
been linked to the experience of nonhistaminergic itch as well[71].
While the biological mechanisms underlying cowhage-evoked itch
andAD both require further study, cowhage-evoked itch is believed
to offer a model that more closely resembles itch experienced in AD
than histamine, electrically, or mechanically evoked itch. Future
placebo and nocebo effect experiments on cowhage-evoked itch
could provide new insights in the possible underlying placebo and
nocebo mechanisms that may differ between acute itch and chronic
pruritic conditions, such as AD.
Whereas cowhage provides a more representative experi-
mental model of AD than histamine, allergens can be used in
samples with allergic hypersensitivity to experimentally model
the pruritic symptoms observed in allergic responses, though
histamine can be used in this role as well. Administering hista-
mine may be a more practical alternative, due to the greater
response rate and better documented itch response. Whereas
administering allergens may require multiple, different allergic
compounds based on an participant’s allergy, administering his-
tamine to all participants in a given experiment allows for a more
homogenous sample.
Audiovisual methods of evoking itch provide a purely psy-
chological method of evoking and studying itch experimentally.
So far, one study has used itch-evoking videos paired with verbal
suggestions to induce a nocebo-like effect on scratching behavior
caused by the videos[43]. While nearly all placebo and nocebo itch
studies conducted so far have used itch-evoking stimuli applied to
the skin, future research could combine expectancy-induction
methods with audiovisual stimuli to study how expectancies
affect the perception of nonphysiological itch-evoking stimuli.
Audiovisual stimuli may also be used to modulate perception of
another itch-evoking stimulus such as mechanical stimulation or
histamine[29].
All the itch-evoking stimuli described in this review, including
cowhage, are known to be compatible with neuroimaging
methods (eg, fMRI) when the appropriate equipment is
used[58,72–76]. Although 2 studies have investigated nocebo effects
on itch with fMRI, to date no neuroimaging studies of placebo
effects on itch have been published. More research with neuroi-
maging of placebo and nocebo effects on itch with fMRI com-
patible itch-evocation methods is warranted. Such research
would provide a better understanding of the neurobiological
mechanisms of these effects, and of the neural correlates of the
learning processes commonly involved in placebo and nocebo
research.
Future research toward clinical applications
So far, we have described ideas for future research specific to itch-
evoking and expectancy-inducing methods predominately from a
methodological perspective. Here we describe themost important
findings of this review in regards to suggestions for future
research specifically aimed at advancing the clinical application
of research on placebo and nocebo effects on itch. First, future
research on placebo and nocebo effects on itch should move
toward increased clinical relevance and transferability. At pre-
sent, most studies of placebo and nocebo effects on itch use itch-
evoking and expectancy-inducing methods tailored to study the
existence andmechanisms of these effects, with less attention paid
to the clinical transferability of these methods.While histamine or
electrical stimulation have been used to evoke itch in placebo and
nocebo studies of healthy participants, the use of a clinically
transferable model of itch such as cowhagemay advance both our
mechanistic understanding of placebo and nocebo effects as well
as advance the clinical relevance of research in this field. Studies
using cowhage with clinical populations (eg, AD patients)[77] are
also warranted for these reasons. A detailed understanding of the
unique and shared effects of verbal suggestions and conditioning
on placebo and nocebo effects will be important for advancing
effective treatments for nocebo effects on itch in dermatological
and systemic disorders. Verbal suggestions that more closely
resemble the instructions given by health care providers in clinical
practice, or written suggestions resembling the information
patients my find about disorders through online resources could
also be studied. Currently, the verbal suggestions used in
laboratory research do not generally resemble the sort of verbal
information which may be used in the clinic. This is particularly
relevant for placebo studies, which typically used verbal sugges-
tions (eg, stating that a pill reduces sensitivity to physical sensa-
tions in 95% of users)[39] to induce placebo effects on inert
substances (eg, a sugar pill). Studying how verbal suggestions can
enhance the efficacy of active treatments may provide more
clinically applicable results. For example, Varelmann et al[78],
examined the effect on pain resulting from different verbal sug-
gestions preceding the injection of a local anesthetic for women in
childbirth. Similarly, future research in this field could investigate
how itch-relieving treatments are impacted by either neutral or
positive remarks made by the experimenter or practitioner
administering the treatment. Finally, observational learning
could be studied as a learning process by which placebo and
nocebo effects can be induced, in addition to instructional (ie,
verbal suggestion) and associative (ie, conditioning) learning. For
example, patients may learn by seeing and hearing about the
treatment outcomes of fellow patients in doctors’ waiting rooms
and patient support groups. Results from several studies of pla-
cebo and nocebo effects on pain suggest that observational
learning can yield effects of comparable strength to those of
conditioning methods[79–81]; however, this process has not yet
been studied in itch. Further research on these learning process
that also addresses the current gap in clinical applications of
placebo effects and detection or prevention of nocebo effects
would help to advance the field.
Clinical transferability of our understanding of placebo and
nocebo effects will benefit from further research on how to prevent
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individuals from developing nocebo effects through learning pro-
cesses. Methods to hinder or reverse the effects of conditioning
could also be explored. These include counterconditioning, con-
ditioning positive outcome associations with stimuli that were
previously associated with negative outcomes (eg, pairing the
administration of a cream that formerly preceded a high itch
response with a low itch response)[19], and latent inhibition,
exposing patients to treatment related stimuli (e.g. the treatment
setting, medical devices) in the absence of a treatment to weaken the
association with negative treatment-outcome expectancies (eg, fear
of side effects)[82]. Evidence from a study on healthy participants
indicates that counterconditioning can reduce experimentally
induced nocebo effects and induce placebo effects on itch[20]. Future
research could investigate the efficacy of counterconditioning on
longstanding nocebo effects, as nocebo effects may pose the greatest
risk in chronic conditions where the opportunity for learning and
reinforcing negative expectancies is greatest. Latent inhibition
methods have not yet been investigated as a means of preventing
nocebo effects. Future research could first test latent inhibition as a
means of blunting experimentally conditioned nocebo effects in
healthy samples, by exposing participants to a nocebo stimulus (eg,
inert cream) before it is paired with an itch response, and later in
clinical settings, by providing patients with a chance to experience
the treatment environment and learn about the treatment proce-
dures before undergoing then. Especially when combined with
verbal suggestions explaining the purpose of latent inhibition, such
methods may be effective at preventing nocebo effects altogether.
Experimental conditioning methods could also be extended to
research on patients as a means of reducing reliance on medication
by conditioning associations with the effects of a medication. Work
on this line of research has already begun, such as in studies where
an association was conditioned between antihistamine medication
effects and a novel tasting drink, so that the drink could evoke a
response similar to that of the medication after conditioning[83,84],
and for the treatment of psoriasis with lower doses of medication
following conditioning of themedication effects[85]. Future research
on these topics offers a path toward translating scientific results into
improvements in clinical practice.
Conclusions
In conclusion, research has only recently begun on placebo and
nocebo effects on itch, and our understanding of these effects is
growing rapidly. More research has been done on pain, and those
findings can inform the research conducted on itch. Placebo and
nocebo effects on itch have been induced with verbal suggestion,
conditioning, and the combination of these methods for a variety of
pruritic and inert compounds. Taken together, the results of these
studies demonstrate that placebo and nocebo effects, induced by
positive and negative outcome expectancies, can substantially affect
the experience of itch. Future research examining effective expec-
tancy inductions for itch and optimal methods and circumstances
for itch-evoking stimuli will advance our understanding of the
learning processes that underlie placebo and nocebo effects. More
research should be conducted with clinical populations, preferably
with condition-relevant itch stimuli, to advance basic understanding
of placebo effects and treatments for nocebo effects in pruritic
conditions. With a better understanding of how the learning pro-
cesses underlying placebo and nocebo effects function in clinical
settings, we can tailor treatments around promoting positive
outcome expectancies and placebo effects, andminimize the risks of
patients developing nocebo effects.
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